Literature DB >> 20458574

Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.

M R Allen1, D J Kubek, D B Burr, S L Ruggiero, T-M G Chu.   

Abstract

UNLABELLED: The goal of this study was to document how treatment with high doses of zoledronic acid affects dental extraction healing. Our results, showing significantly compromised osseous healing within the socket as well as presence of exposed bone and development of a sequestrum in one animal, provide a building block toward understanding osteonecrosis of the jaw.
PURPOSE: The goal of this study was to document how treatment with a bisphosphonate affects the bone tissue following dental extraction.
METHODS: Skeletally mature female beagle dogs were either untreated controls (CON) or treated with intravenous zoledronic acid (ZOL). Following the extraction of the fourth premolars, healing was allowed for 4 or 8 weeks. Properties of the extraction site were assessed using microcomputed tomography (micro-CT) and dynamic histomorphometry.
RESULTS: The initial infilling of the extraction socket with bone was not affected by ZOL, but subsequent removal of this bone was significantly suppressed compared to CON. After 8 weeks of healing, the alveolar cortical bone adjacent to the extraction socket had a remodeling rate of ∼50% per year in CON animals while ZOL-treated animals had a rate of <1% per year. One ZOL-treated animal developed exposed bone post-extraction which eventually led to the formation of a sequestrum. Assessment of the sequestrum with micro-CT and histology showed that it had features consistent with those reported in humans with osteonecrosis of the jaw.
CONCLUSIONS: These results, showing significantly compromised post-extraction osseous healing as well as presence of exposed bone and development of a sequestrum in one ZOL animal, provide a building block toward understanding the pathophysiology of osteonecrosis of the jaw.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458574      PMCID: PMC2999646          DOI: 10.1007/s00198-010-1268-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

Review 1.  Post-extraction remodeling of the adult mandible.

Authors:  V J Kingsmill
Journal:  Crit Rev Oral Biol Med       Date:  1999

2.  Dynamics of bone tissue formation in tooth extraction sites. An experimental study in dogs.

Authors:  G Cardaropoli; M Araújo; J Lindhe
Journal:  J Clin Periodontol       Date:  2003-09       Impact factor: 8.728

Review 3.  Bone quality--the material and structural basis of bone strength and fragility.

Authors:  Ego Seeman; Pierre D Delmas
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

4.  Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Authors:  Salvatore L Ruggiero; John Fantasia; Eric Carlson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-07-31

5.  Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.

Authors:  Kostas Zervas; Evgenia Verrou; Zisis Teleioudis; Konstantinos Vahtsevanos; Anastasia Banti; Dimitra Mihou; Dimitris Krikelis; Evangelos Terpos
Journal:  Br J Haematol       Date:  2006-08-01       Impact factor: 6.998

Review 6.  Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.

Authors:  Martha Q Lacy; Angela Dispenzieri; Morie A Gertz; Philip R Greipp; Kimberly L Gollbach; Suzanne R Hayman; Shaji Kumar; John A Lust; S Vincent Rajkumar; Stephen J Russell; Thomas E Witzig; Steven R Zeldenrust; David Dingli; P Lief Bergsagel; Rafael Fonseca; Craig B Reeder; A Keith Stewart; Vivek Roy; Robert J Dalton; Alan B Carr; Deepak Kademani; Eugene E Keller; Christopher F Viozzi; Robert A Kyle
Journal:  Mayo Clin Proc       Date:  2006-08       Impact factor: 7.616

7.  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Authors:  Tony Mavrokokki; Andrew Cheng; Brien Stein; Alastair Goss
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

Review 8.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Authors:  Sook-Bin Woo; John W Hellstein; John R Kalmar
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

9.  Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.

Authors:  Mark J Clemons; George Dranitsaris; Wei S Ooi; Geetha Yogendran; Tatjana Sukovic; Betty Y L Wong; Sunil Verma; Kathleen I Pritchard; Maureen Trudeau; David E C Cole
Journal:  J Clin Oncol       Date:  2006-09-25       Impact factor: 44.544

10.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

View more
  17 in total

Review 1.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

2.  Clodronate-Loaded Liposome Treatment Has Site-Specific Skeletal Effects.

Authors:  M N Michalski; L E Zweifler; B P Sinder; A J Koh; J Yamashita; H Roca; L K McCauley
Journal:  J Dent Res       Date:  2019-01-09       Impact factor: 6.116

3.  Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.

Authors:  D J Kubek; D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2010-11       Impact factor: 1.826

4.  Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.

Authors:  James E Tisdale; Matthew R Allen; Brian R Overholser; Heather A Jaynes; Richard J Kovacs
Journal:  J Cardiovasc Electrophysiol       Date:  2015-03-31

5.  In vivo effects of zoledronic acid on oral mucosal epithelial cells.

Authors:  E Allam; Mr Allen; T-M Chu; A Ghoneima; L Jack Windsor
Journal:  Oral Dis       Date:  2010-09-23       Impact factor: 3.511

6.  A novel model of bisphosphonate-related osteonecrosis of the jaw in rats.

Authors:  Huawei Yang; Hui Pan; Fang Yu; Kai Chen; Guangwei Shang; Yuanzhi Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.

Authors:  Matthew R Allen; Tien-Min Gabriel Chu; Salvatore L Ruggiero
Journal:  J Oral Maxillofac Surg       Date:  2013-02-01       Impact factor: 1.895

8.  Multiple systemic diseases complicated by bisphosphonate osteonecrosis: a case report.

Authors:  Fabrizio Carini; Lorena Barbano; Vito Saggese; Dario Monai; Gianluca Porcaro
Journal:  Ann Stomatol (Roma)       Date:  2012-11-14

Review 9.  Atraumatic tooth extraction in patients taking bisphosphonates: a review of literature and experience with three cases.

Authors:  Sebastian Hoefert; Martin Grimm; Feraydoon Sharghi; Andreas Geist; Michael Krimmel; Siegmar Reinert
Journal:  Oral Maxillofac Surg       Date:  2014-05-15

10.  Molecular alterations of bone quality in sequesters of bisphosphonates-related osteonecrosis of the jaws.

Authors:  C Olejnik; G Falgayrac; A During; M H Vieillard; J M Maes; B Cortet; G Penel
Journal:  Osteoporos Int       Date:  2013-10-01       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.